Talaris Therapeutics Inc.

09/26/2023 | Press release | Distributed by Public on 09/26/2023 06:25

Regulation FD Disclosure - Form 425

TALARIS THERAPEUTICS, INC.
Date: September 26, 2023 By:

/s/ Mary Kay Fenton

May Kay Fenton
Chief Financial Officer and Interim Chief Financial Officer